Medacta to Debut GMK SpheriKA Femoral Implant

Medacta will debut GMK SpheriKA, a kinematic alignment (KA)-optimized femoral component for total knee replacement, at the 2023 American Association of Hip and Knee Surgeons (AAHKS) annual meeting.
 
Kinematic alignment restores the native pre-arthritic alignment via anatomic resurfacing, minimizing ligament releases, and allowing more natural knee kinematic. Medacta says clinical studies have highlighted the GMK Sphere is a suitable implant for KA, and could possibly further enhance outcomes compared to other knee designs.
 
GMK SpheriKA is built on the GMK Sphere’s legacy ball-in-socket design. Medacta says the implant can feel more natural and stable during daily activities because it replicates a healthy knee’s movement. Further, the company said GMK SpheriKA’s features of optimized femoral coverage and patellar tracking for KA procedures make it the first implant on the market specifically designed for the technique.
 
“GMK SpheriKA further reinforces Medacta’s commitment to providing surgeons with personalized solutions for each of their patients,” Medacta CEO Francesco Siccardi told the press.”By working together with an international team of orthopaedic surgeon experts, we have introduced a product that builds upon our clinically proven GMK Sphere and incorporates the fundamentals of Kinematic Alignment to ensure that each patient receives an implant that can accommodate their unique anatomy.”
 
“I am thrilled to offer the GMK SpheriKA to my patients,” added surgeon developer and Kinematic Alignment pioneer Stephen Howell, MD.”The implant design provides a personalized option that addresses each patient’s unique anatomy and patellofemoral kinematics, restoring a more normal feeling knee and a quick return of motion and daily activities.”